Transcode Therapeutics, Inc. (RNAZ) stock
RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.41+0.06 (+4.44%)
Close on Nov 17, 2026Market cap $1.43MP/E –Yield –
Transcode Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Transcode Therapeutics's price to book ratio was 3.3× on Jul 31, 2026, against 25.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 3.3× | −0.7 |
| 2025 | Dec 31, 2025 | 4.0× | −323.9 |
| 2024 | Jul 31, 2024 | 327.9× | – |
See a number that looks wrong?